SmallCapVoice » LLBO http://smallcapvoice.com/blog "One of today's leaders in investor relations and shareholder services" Fri, 10 Feb 2012 21:00:12 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 http://smallcapvoice.com/blog/feed/podcast/ SmallCapVoice: We Specialize in Covering Small Cap Stocks & Providing Small Cap Investor Relations with our Investing Tools for the Small Cap Investor SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its newsletter to feature its daily small cap stock picks, audio interviews, as well as its client's financial news releases. SmallCapVoice.com also offers individual investors with all the tools they need to make informed decisions about the small cap stocks they are interested in. Tools like our stock charts, stock alerts, and our investor fact sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. Stuart Smith no Stuart Smith thogue@smallcapvoice.com thogue@smallcapvoice.com (Stuart Smith) SmallCapVoice.com Small Cap Stocks, Investor Relations Investing, Finance, Business, Small Cap Stock, Audio Interview, Stock, SmallCapVoice, OTC Stock SmallCapVoice » LLBO http://smallcapvoice.com/blog/wp-content/uploads/powerpress/SmallCapVoice.com-352.jpg http://smallcapvoice.com/blog Jim Holmes, CEO of Lifeline Biotechnologies, Inc., and Dr. Louis Keith, president of First Warning Systems(TM), Inc. are the Featured Guests in an Audio Interview at SmallCapVoice.com http://smallcapvoice.com/blog/llbo-10-13-08/ http://smallcapvoice.com/blog/llbo-10-13-08/#comments Wed, 31 Dec 2008 00:30:27 +0000 Tom http://smallcapvoice.com/blog/?p=3 SmallCapVoice.com, Inc. announces that a new audio interview featuring Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO), and its subsidiary, First Warning Systems™, Inc. is now available at SmallCapVoice.com. The interview can be heard here at http://smallcapvoice.com/blog/10-13-08-audio-interview-with-lifeline-biotechnologies-inc-otcpk-llbo/

SmallCapVoice.com is a corporate investor relations firm known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its client’s financial news releases. SmallCapVoice.com offers individual investors with the tools they need to make informed decisions about the stocks they are interested in. To learn more about SmallCapVoice.com, please visit http://www.smallcapvoice.com/services.html.

About Lifeline Biotechnologies, Inc:

Lifeline Biotechnologies, Inc. is an innovative medical technology company that is focused on completing the development of the First Warning System™, which is designed to assist in the early detection of breast cancer. Of the approximately $138 billion spent on cancer each year, Lifeline could potentially save the healthcare industry billions of dollars annually, assuming the following are successfully completed: Clinical trials (if required) and filing and receiving a 510(k) from the FDA, and the product is successfully established in the marketplace.

Lifeline competes in the money markets for funds to support the development of its product. The cost of funds, for early stage companies like Lifeline, are expensive and the terms have been, and may continue to be, dilutive. www.lbti.com

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing, successful development of the Company’s product and regulatory and shareholder approval for anticipated actions.

SmallCapVoice.com, Inc.
Stuart T. Smith, 512-267-2430
Info@smallcapvoice.com
or
e-media Direct, Inc.
Investor Relations, 866-284-2835
info@e-mediadirect.com

TwitterStumbleUponFacebookLinkedInTechnorati FavoritesDeliciousDiggFarkNewsVineNetvibes SharePrintFriendlyGoogle GmailMySpaceBlogger PostAOL MailYahoo BookmarksWordPressYahoo MailShare

]]> http://smallcapvoice.com/blog/llbo-10-13-08/feed/ 0 Interview,LLBO SmallCapVoice.com, Inc. announces that a new audio interview featuring Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO), and its subsidiary, First Warning Systems™, Inc. is now available at SmallCapVoice.com. SmallCapVoice.com, Inc. announces that a new audio interview featuring Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO), and its subsidiary, First Warning Systems™, Inc. is now available at SmallCapVoice.com. The interview can be heard here at http://smallcapvoice.com/blog/10-13-08-audio-interview-with-lifeline-biotechnologies-inc-otcpk-llbo/ SmallCapVoice.com is a corporate investor relations firm known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its client’s financial news releases. SmallCapVoice.com offers individual investors with the tools they need to make informed decisions about the stocks they are interested in. To learn more about SmallCapVoice.com, please visit http://www.smallcapvoice.com/services.html. About Lifeline Biotechnologies, Inc: Lifeline Biotechnologies, Inc. is an innovative medical technology company that is focused on completing the development of the First Warning System™, which is designed to assist in the early detection of breast cancer. Of the approximately $138 billion spent on cancer each year, Lifeline could potentially save the healthcare industry billions of dollars annually, assuming the following are successfully completed: Clinical trials (if required) and filing and receiving a 510(k) from the FDA, and the product is successfully established in the marketplace. Lifeline competes in the money markets for funds to support the development of its product. The cost of funds, for early stage companies like Lifeline, are expensive and the terms have been, and may continue to be, dilutive. www.lbti.com Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing, successful development of the Company’s product and regulatory and shareholder approval for anticipated actions. SmallCapVoice.com, Inc. Stuart T. Smith, 512-267-2430 Info@smallcapvoice.com or e-media Direct, Inc. Investor Relations, 866-284-2835 info@e-mediadirect.com Stuart Smith no 10-13-08 Audio Interview with Lifeline Biotechnologies, Inc. (OTCPK: LLBO) http://smallcapvoice.com/blog/10-13-08-audio-interview-with-lifeline-biotechnologies-inc-otcpk-llbo/ http://smallcapvoice.com/blog/10-13-08-audio-interview-with-lifeline-biotechnologies-inc-otcpk-llbo/#comments Mon, 13 Oct 2008 16:12:09 +0000 Tom http://smallcapvoice.com/blog/?p=998 Lifeline Biotechnologies, Inc. is an innovative medical technology company that is focused on completing the development of the First Warning System™, which was designed to assist in the early detection of breast cancer. Of the approximately $138 billion spent on cancer each year, Lifeline could potentially save the healthcare industry up to $4.1 billion annually, assuming the following are successfully completed: the development of the First Warning System™, the completion of clinical trials and FDA pre-marketing clearance. Additional information can be found on the Company’s website at: www.lbti.com.

Lifeline competes in the money markets for funds to support the development and commercialization of its products. The cost of funds, for early stage companies like Lifeline, is expensive and the terms have been, and may continue to be, dilutive.

TwitterStumbleUponFacebookLinkedInTechnorati FavoritesDeliciousDiggFarkNewsVineNetvibes SharePrintFriendlyGoogle GmailMySpaceBlogger PostAOL MailYahoo BookmarksWordPressYahoo MailShare

]]> http://smallcapvoice.com/blog/10-13-08-audio-interview-with-lifeline-biotechnologies-inc-otcpk-llbo/feed/ 0 Interview,LLBO Lifeline Biotechnologies, Inc. is an innovative medical technology company that is focused on completing the development of the First Warning System™, which was designed to assist in the early detection of breast cancer. Lifeline Biotechnologies, Inc. is an innovative medical technology company that is focused on completing the development of the First Warning System™, which was designed to assist in the early detection of breast cancer. Of the approximately $138 billion spent on cancer each year, Lifeline could potentially save the healthcare industry up to $4.1 billion annually, assuming the following are successfully completed: the development of the First Warning System™, the completion of clinical trials and FDA pre-marketing clearance. Additional information can be found on the Company’s website at: www.lbti.com. Lifeline competes in the money markets for funds to support the development and commercialization of its products. The cost of funds, for early stage companies like Lifeline, is expensive and the terms have been, and may continue to be, dilutive. Stuart Smith no